![Steven Favaloro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Favaloro
Directeur Général chez
Genezen Laboratories, Inc.
Profil
Steven J.
Favaloro is currently the Chairman, President & Chief Executive Officer at Genezen Laboratories, Inc. He is also a Strategic Advisor at Kineticos Ventures LLC and an Executive Advisor at Ampersand Management LLC.
Previously, he served as the Chief Financial Officer at Arranta Bio Holdings LLC, Brammer Bio LLC, and Arbor Biotechnologies, Inc. Mr. Favaloro completed his undergraduate degree at Boston College in 2008.
He then pursued graduate studies at the Wallace E Carroll School of Management, where he obtained an MBA in 2013.
Postes actifs de Steven Favaloro
| Sociétés | Poste | Début |
|---|---|---|
Genezen Laboratories, Inc.
 Genezen Laboratories, Inc. BiotechnologyHealth Technology Operates as cell and gene therapy contract development & manufacturing organization | Directeur Général | 13/03/2023 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Consultant / Advisor | 01/03/2023 |
Kineticos Ventures LLC
 Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of bio technology sectors. It provides financing for growth stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Steven Favaloro
| Sociétés | Poste | Fin |
|---|---|---|
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Directeur Financier/CFO | 01/03/2023 |
Arranta Bio Holdings LLC
 Arranta Bio Holdings LLC BiotechnologyHealth Technology Develops and manufactures biological drugs and therapies | Directeur Financier/CFO | 01/02/2022 |
Brammer Bio LLC
 Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | 01/09/2019 |
Formation de Steven Favaloro
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
 Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Arranta Bio Holdings LLC
Arranta Bio Holdings LLC BiotechnologyHealth Technology Develops and manufactures biological drugs and therapies | Health Technology |
Genezen Laboratories, Inc.
Genezen Laboratories, Inc. BiotechnologyHealth Technology Operates as cell and gene therapy contract development & manufacturing organization | Health Technology |
Kineticos Ventures LLC
Kineticos Ventures LLC Investment ManagersFinance Kineticos Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of bio technology sectors. It provides financing for growth stage capital requirements. | Finance |
